AASTOCKS
2022.06.22 04:25

百心安近 2,500 万人民币参股医疗器械开发商 15.42%

百心安-B 公布,透过收购及注资,收购心血管医疗器械开发业务 - 上海心至医疗科技 15.42% 权益,现金总代价 2,466 万人民币 (约 2,895 万港元)。

百心安-B(02185.HK) 公布,透过收购及注资,收购心血管医疗器械开发业务 - 上海心至医疗科技 15.42% 权益,现金总代价 2,466 万人民币 (约 2,895 万港元)。(de/d)
The copyright of this article belongs to the original author/organization.
The current content only represents the author’s point of view, and has nothing to do with the position of Longbridge. The content is for investment reference only and does not constitute any investment advice. If you have any questions or suggestions about the content services provided by Longbridge, please contact: editorial@longbridge.global

Like